Apalutamide and Leuprolide in Intermediate and High-risk Prostate Cancer

NCT02770391 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Leuprolide acetate
DRUG: Apalutamide
PROCEDURE: Radical prostatectomy

Sponsor

Case Comprehensive Cancer Center